Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...
In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...
A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's natural immune defenses, is a key driver of inflammatory responses that ...
New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Mary Scourboutakos, Eastern Virginia Medical School (THE CONVERSATION) Most prenatal ...
WASHINGTON -- The high rate of premature births in the United States constitutes a public health concern that costs society at least $26 billion a year, according to a new report from the Institute of ...
New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.
Mary J. Scourboutakos does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results